Literature DB >> 12595574

Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.

Jennifer J Hill1, Yongchang Qiu, Rodney M Hewick, Neil M Wolfman.   

Abstract

Myostatin, a member of the TGFbeta superfamily, is a potent and specific negative regulator of skeletal muscle mass. In serum, myostatin circulates as part of a latent complex containing myostatin propeptide and/or follistatin-related gene (FLRG). Here, we report the identification of an additional protein associated with endogenous myostatin in normal mouse and human serum, discovered by affinity purification and mass spectrometry. This protein, which we have named growth and differentiation factor-associated serum protein-1 (GASP-1), contains multiple domains associated with protease-inhibitory proteins, including a whey acidic protein domain, a Kazal domain, two Kunitz domains, and a netrin domain. GASP-1 also contains a domain homologous to the 10-cysteine repeat found in follistatin, a protein that binds and inhibits activin, another member of the TGFbeta superfamily. We have cloned mouse GASP-1 and shown that it inhibits the biological activity of mature myostatin, but not activin, in a luciferase reporter gene assay. Surprisingly, recombinant GASP-1 binds directly not only to mature myostatin, but also to the myostatin propeptide. Thus, GASP-1 represents a novel class of inhibitory TGFbeta binding proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595574     DOI: 10.1210/me.2002-0366

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  76 in total

1.  Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Authors:  Kevin J Morine; Lawrence T Bish; Joshua T Selsby; Jeffery A Gazzara; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; Se-Jin Lee; H Lee Sweeney
Journal:  Muscle Nerve       Date:  2010-11       Impact factor: 3.217

2.  METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.

Authors:  Alexandra C McPherron
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2010-12

3.  Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

Authors:  Se-Jin Lee; Lori A Reed; Monique V Davies; Stefan Girgenrath; Mary E P Goad; Kathy N Tomkinson; Jill F Wright; Christopher Barker; Gregory Ehrmantraut; James Holmstrom; Betty Trowell; Barry Gertz; Man-Shiow Jiang; Suzanne M Sebald; Martin Matzuk; En Li; Li-Fang Liang; Edwin Quattlebaum; Ronald L Stotish; Neil M Wolfman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

4.  Second Kunitz-type protease inhibitor domain of the human WFIKKN1 protein.

Authors:  Edvards Liepinsh; Alinda Nagy; Mária Trexler; László Patthy; Gottfried Otting
Journal:  J Biomol NMR       Date:  2006-06-01       Impact factor: 2.835

5.  Molecular cloning and characterization of follistatin in the gilthead sea bream, Sparus aurata.

Authors:  Bruria Funkenstein; Yanai Rebhan; Tal Skopal
Journal:  Mol Biol Rep       Date:  2008-01-01       Impact factor: 2.316

6.  Novel strategies for improving physical function.

Authors:  Shalender Bhasin; Ravi Jasuja; Powen Tu; Thomas W Storer; Wen Guo
Journal:  Horm Res Paediatr       Date:  2011-07-21       Impact factor: 2.852

7.  Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.

Authors:  Raouia Fakhfakh; Se-Jin Lee; Jacques P Tremblay
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

8.  Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Authors:  Ferrill F Rose; Virginia B Mattis; Hansjörg Rindt; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

9.  Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Authors:  Kevin J Morine; Lawrence T Bish; Klara Pendrak; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

10.  Agrin binds BMP2, BMP4 and TGFbeta1.

Authors:  László Bányai; Peter Sonderegger; László Patthy
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.